Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

École de technologie supérieure

$20,000.00

Characterization and optimization of bioactive coatings for vascular applications

EF 2014-15

Résumé
Cardiovascular diseases are the most important cause of morbidity and mortality in industrialised countries like Canada. Minimally-invasive therapies using endovascular implants inserted by catheters have been developed that offer numerous advantages over conventional surgeries, including reduced risks of mortality, decreased blood loss and shorter recovery and hospitalisation times. Yet, their efficacy is often jeopardized by frequent clinical complications. As chairman of the Canada Research Chair in Biomaterials and endovascular implants, Lerouge aims to improve these implants and therapies by developing clinically-suitable strategies. This research program is focused on bioactive coatings designed to counter the inherent shortcomings of synthetic polymers used for endovascular implants. Our approach is to develop a versatile method using plasma-polymerized coatings that can be deposited on a wide variety of surfaces. These films were shown to exhibit excellent cell adhesion properties. More importantly, their chemical composition allows easy and efficient immobilisation of biomolecules for the control of the biological response. Yet several issues (adhesion, sterilizability, stability ...) remain to be addressed before transfering these innovative coatings onto realistic implants. This research program will enable optimization and characterization of bioactive coatings for a new generation of vascular and endovascular implants with less clinical complications. The engineering tools and methods developed will later also be applicable to other coatings and pathologies. Benefits will include multidisciplinary training of highly qualified personnel in this very strategic research field for Canada. Lerouge's close collaborations with clinicians and industry in this strategically-important field for Canada constitute keys for success.
Programme
Discovery Grants Program - Individual
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
298225-2010
Name nom
Lerouge, Sophie
Department département
Génie mécanique
Organization id
53
Institution établissement
École de technologie supérieure
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2010
Award amount
20000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1511
Committee name en
Materials and Chemical Engineering
Committee name fr
Génie chimique et des matériaux
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1902
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical materials
Research subject fr
Matériaux biomédicaux
Partie
5
Nb partie
5
Application title
Characterization and optimization of bioactive coatings for vascular applications
Keyword
NSERC
Application summary
Cardiovascular diseases are the most important cause of morbidity and mortality in industrialised countries like Canada. Minimally-invasive therapies using endovascular implants inserted by catheters have been developed that offer numerous advantages over conventional surgeries, including reduced risks of mortality, decreased blood loss and shorter recovery and hospitalisation times. Yet, their efficacy is often jeopardized by frequent clinical complications. As chairman of the Canada Research Chair in Biomaterials and endovascular implants, Lerouge aims to improve these implants and therapies by developing clinically-suitable strategies. This research program is focused on bioactive coatings designed to counter the inherent shortcomings of synthetic polymers used for endovascular implants. Our approach is to develop a versatile method using plasma-polymerized coatings that can be deposited on a wide variety of surfaces. These films were shown to exhibit excellent cell adhesion properties. More importantly, their chemical composition allows easy and efficient immobilisation of biomolecules for the control of the biological response. Yet several issues (adhesion, sterilizability, stability ...) remain to be addressed before transfering these innovative coatings onto realistic implants. This research program will enable optimization and characterization of bioactive coatings for a new generation of vascular and endovascular implants with less clinical complications. The engineering tools and methods developed will later also be applicable to other coatings and pathologies. Benefits will include multidisciplinary training of highly qualified personnel in this very strategic research field for Canada. Lerouge's close collaborations with clinicians and industry in this strategically-important field for Canada constitute keys for success.